Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000137

Director sold 21,332 shares at an average $79.51 ($1,696,181)

  • Director acquired 16,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

KLEIN JOSEPH III · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-03 Exercise or conversion : show line 1 in the form 10b5-1 +12,000 $40.05 $480,600 28,346 D
2026-03-03 Exercise or conversion : show line 2 in the form 10b5-1 +4,000 $42.88 $171,520 32,346 D
2026-03-03 Sale : show line 3 in the form 10b5-1 −13,526 $79.17 $1,070,908 18,820 D
2026-03-03 Sale : show line 4 in the form 10b5-1 −6,794 $80.00 $543,486 12,026 D
2026-03-03 Sale : show line 5 in the form 10b5-1 −1,012 $80.82 $81,788 11,014 D
Open-market sales · 21,332 sh · avg $79.51 · $1,696,181

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-03 Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −12,000 0 D
2026-03-03 Exercise or conversion : show line 7 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −4,000 0 D
Loading xslF345X05/edgardoc.xml…